うさ研 founded in 2006
２０２２
２０２２年 |
|---|
| 1. 原著論文 1. Masato Takase, Tomohiro Nakamura, Takumi Hirata, Naho Tsuchiya, Mana Kogure, FumiItabashi, Naoki Nakaya, Yohei Hamanaka, Junichi Sugawara, Kichiya Suzuki, Nobuo Fuse, AkiraUruno, Eiichi N Kodama, Shinichi Kuriyama, Ichiro Tsuji, Shigeo Kure, and Atsushi Hozawa.Associations between the combined fat mass index and fat-free mass index with hemoglobin A1c ina Japanese population: The Tohoku Medical Megabank Community-based Cohort Study. Journal of Diabetes Investigation 13:858-867, 2022 doi: 10.1111/jdi.13729 2. Nobuo Fuse, Miyuki Sakurai, Ikuko N. Motoike, Takako Takai-Igarashi, Naoki Nakaya, NahoTsuchiya, Tomohiro Nakamura, Mami Ishikuro, Taku Obara, Akiko Miyazawa, Kei Homma, KeisukeIdo, Makiko Taira, Tomoko Kobayashi, Ritsuko Shimizu, Akira Uruno, Eiichi N. Kodama, KichiyaSuzuki, Yohei Hamanaka, Hiroaki Tomita, Junichi Sugawara, Yoichi Suzuki, Fuji Nagami, SoichiOgishima, Fumiki Katsuoka, Naoko Minegishi, Atsushi Hozawa, Shinichi Kuriyama, Nobuo Yaegashi,Shigeo Kure, Kengo Kinoshita, and Masayuki Yamamoto. Genome-wide association study of axiallength in population-based cohorts of a Japanese population: the Tohoku Medical MegabankOrganization Eye Study. Ophthalmology Science 2:100113, 2022 doi:10.1016/j.xops.2022.100113 ３．Naoya Itoh, Nana Akazawa, Eri Kanawaku, Hiromi Murakami, Yuichi Ishibana, DaichiKawamura, Takanori Kawabata, Keita Mori, Eiichi N. Kodama, Norio Ohmagari. Effects of infectiousdisease consultation and antimicrobial stewardship program at a Japanese cancer center: Aninterrupted time-series analysis. PLoS ONE 17:e0263095, 2022 doi.org/10.1371/journal.pone.0263095 ４．Yoshitsugu Ohata, Mitsunori Tomonaga, Yasuo Watanabe, Keiko Tomura, Koji Kimura, TatsuoAkaki, Kaoru Adachi, Eiichi N Kodama, Yuji Matsuzaki, Hironori Hayashi. Antiviral Activity andResistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor, JTP-0157602. Journal of Virology 96:e01843-21, 2022. doi: 10.1128/JVI.01843-21 新たなHIVインテグラーゼ阻害剤の作用機序、効果、耐性機序に触れた論文です。 論文公表後からすでに多く引用されています。日本たばこ産業（JT）との産学共同研究です。 ５．Shinichiro Morioka, Ban Hock Tan, Hiroe Kikuchi, Yusuke Asai, Tetsuya Suzuki, Shinobu Ashida,Satoshi Kutsuna, Sho Saito, Kayoko Hayakawa, Thuan Tong Tan, Eiichi Kodama, Norio Ohmagari.Factors associated with prolonged psychological distress among nurses and physicians engaged inCOVID-19 patient care in hospitals in Singapore and Japan. Frontiers in Psychiatry13:781796, 2022 doi.org/10.3389/fpsyt.2022.781796 ６．Yuko Makino, Chihiro Oe, Kazuya Iwama, Satoshi Suzuki, Akie Nishiyama, Kazuya Hasegawa,Haruka Okuda, Kazushige Hirata, Mariko Ueno, Kumi Kawaji, Mina Sasano, Emiko Usui, ToshiakiHosaka, Yukako Yabuki, Mikako Shirouzu, Makoto Katsumi, Kazutaka Murayama, Hironori Hayashi,Eiichi N. Kodama. Serine hydroxymethyltransferase as a potent target of antibacterial agents actingsynergistically with one-carbon metabolism-related inhibitors. Communications Biology 5:619, 2022 doi:10.1038/s42003-022-03555-x ７．Noriko Iwamoto, Naho Morisaki, Kazuhiro Uda, Masashi Kasai, Eiichi Kodama, Norio Ohmagari,Isao Miyairi. Change in Use of Pediatric Oral Antibiotics in Japan: Pre and post AMR action plan.Pediatrics International 64:e15197, 2022 doi.org/10.1111/ped.15197 ８．Tetsuya Suzuki. Interferon lambda 3 in the early phase of coronavirus disease-19 can predictdisease progression.European Journal of Clinical Investigation 52:e13808, 2022 doi.org/10.1111/eci.13808 ９．Takehiro Yajima, Hiroshi Takahashi, Nozomu Kimura, Kosuke Sato, Daisuke Jingu, SatoshiUbukata, Makoto Shoji, Hiroshi Watanabe, Eiichi N. Kodama, Hidekazu Nishimura. Comparison ofSputum Specimens and Nasopharyngeal Swab Specimens for Diagnosis of Acute HumanMetapneumovirus-related Lower Respiratory Tract Infections in Adults. Journal of Clinical Virology 154:105238, 2022 doi.org/10.1016/j.jcv.2022.105238 10. Naoya Itoh, Nana Akazawa, Masahiro Ishikane, Takanori Kawabata, Daichi Kawamura,Tomoyuki Chikusa, Eiichi N Kodama, Norio Ohmagari. Lessons learned from an outbreak of COVID-19 in the head and neck surgery ward of a Japanese cancer center during the sixth wave byOmicron.Journal of Infection and Chemotherapy 28:1610-1615, 2022. doi: 10.1016/j.jiac.2022.08.010. 2. 症例報告 １．Kengo Oshima, Chie Nakajima, Hajime Kanamori, Kazushige Hirata; Hironori Hayshi, EiichiKodama, Yukari Fukushima; Yukihiko Suzuki, Hiroaki Baba, Tetsuji Aoyagi, Koichi Tokuda, Mitsuo Kaku. Disseminated tuberculosis with paradoxical reactions caused by a Mycobacterium tuberculosis strain belonging to the Indo-Oceanic lineage: An imported case in Japan. Journal of Infection and Chemotherapy 28:965-970, 2022. doi: 10.1016/j.jiac.2022.02.008. ２．Hirohito Sano, Koji Murakami, Hisayuki Yokoyama, Chie Suzuki, Iwasaki Yudai, Eiichi Kodama,Hisatoshi Sugiura. A Rare Case of COVID-19 in a Hairy Cell Leukemia Patient. Tohoku Journal of Experimental Medicine 258:63-68, 2022 doi.org/10.1620/tjem.250.1 3. 学会発表 1. 今年もできないかも・・・。
|
|
1. プレスリリース １． 新聞報道： 夕刊フジ ２． 週刊文春・女性自身など ２．招待講演関連 １． COVID-19のこれまでとこれから 第35回宮城県臨床細胞学会 2月7日 Web開催 ２． COVID-19について 公立藤田総合病院 感染対策セミナー 2月17日 福島県伊達市 2022.11.20: 論文を更新しました 2022.11.10：宮城県古川高等学校の一年生5名が来学してくれました 2022.11.6:「第61回 日本臨床細胞学会秋季大会」専門医認定講習2 |